Pre-existing immunity and hrHPV status determine immunotherapy response in advanced penile cancer: biomarkers and overall survival in the PERICLES trial.
- DOI
- 10.1158/2326-6066.cir-26-0236
- Published
- 2026 Sep 17
- Container
- Cancer immunology research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/2326-6066.cir-26-0236,
title = {Pre-existing immunity and hrHPV status determine immunotherapy response in advanced penile cancer: biomarkers and overall survival in the PERICLES trial.},
author = {Rafael TS and Gil-Jimenez A and Elst L and de Vries HM and Seignette IM and Bekers E and Lopez-Yurda M and Peters D and Nieuwland M and Hooijberg E and Broeks A and Brouwer OR and Schaake EE and Lambrechts D and Wessels LFA and Vis DJ and Albersen M and de Gruijl TD and van der Heijden MS},
year = {2026},
journal = {Cancer immunology research},
doi = {10.1158/2326-6066.cir-26-0236},
url = {https://doi.org/10.1158/2326-6066.cir-26-0236}
}RIS
TY - JOUR TI - Pre-existing immunity and hrHPV status determine immunotherapy response in advanced penile cancer: biomarkers and overall survival in the PERICLES trial. AU - Rafael TS AU - Gil-Jimenez A AU - Elst L AU - de Vries HM AU - Seignette IM AU - Bekers E AU - Lopez-Yurda M AU - Peters D AU - Nieuwland M AU - Hooijberg E AU - Broeks A AU - Brouwer OR AU - Schaake EE AU - Lambrechts D AU - Wessels LFA AU - Vis DJ AU - Albersen M AU - de Gruijl TD AU - van der Heijden MS PY - 2026 JO - Cancer immunology research DO - 10.1158/2326-6066.cir-26-0236 UR - https://doi.org/10.1158/2326-6066.cir-26-0236 ER -
APA
TS, R., A, G., L, E., HM, D. V., IM, S., E, B., M, L., D, P., M, N., E, H., A, B., OR, B., EE, S., D, L., LFA, W., DJ, V., M, A., TD, D. G., & MS, V. D. H. (2026). Pre-existing immunity and hrHPV status determine immunotherapy response in advanced penile cancer: biomarkers and overall survival in the PERICLES trial.. Cancer immunology research. https://doi.org/10.1158/2326-6066.cir-26-0236
Source records
- pubmed · retrieved 2026-09-26T05:16:53.390Z